Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,730 shares at $26.18 ($124K) on 2026-08-17, disclosed to the SEC on 2026-08-19.
Scheduled sale ($124k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |
| ARQT | SELL | 2026-04-03 | $239K | — | Filing → |